Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

MicroRNAs can help regenerate hair by influencing stem cells and immune responses, but delivery challenges exist.

AI can improve hair disorder diagnosis and treatment but can't replace doctors yet.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Ongoing research and innovation are crucial for improving skin care and treatment.

New treatments offer hope for better managing hidradenitis suppurativa.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Genomic approach finds new possible treatments for hair loss.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Some alternative treatments for hair loss might work, but more research is needed.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Exosomes help nerve fibers grow by affecting specific cell signaling pathways.